Merck & Co. (MRK) reported second quarter 2013 earnings of 84 cents per share, two cents above the average estimate of 82 cents. Earnings, however, declined 20% from the year-ago period.
Revenues for the quarter fell 10.6% to $11,010 million, missing consensus estimates of $11,221 million.
Including one-time items, second quarter 2013 earnings declined 48.3% to 30 cents per share.
Pfizer Inc. (PFE) is up +19.46% year-to-date.